- Home
- ELWS vs AEON Comparison
ELWS vs AEON Comparison
Compare ELWS & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- AEON
- Stock Information
- Founded
- ELWS 2018
- AEON N/A
- Country
- ELWS Japan
- AEON United States
- Employees
- ELWS N/A
- AEON N/A
- Industry
- ELWS
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- AEON Health Care
- Exchange
- ELWS Nasdaq
- AEON Nasdaq
- Market Cap
- ELWS 12.9M
- AEON 10.6M
- IPO Year
- ELWS 2023
- AEON N/A
- Fundamental
- Price
- ELWS $5.80
- AEON $0.83
- Analyst Decision
- ELWS
- AEON Strong Buy
- Analyst Count
- ELWS 0
- AEON 1
- Target Price
- ELWS N/A
- AEON $7.20
- AVG Volume (30 Days)
- ELWS 61.0K
- AEON 269.9K
- Earning Date
- ELWS 09-30-2025
- AEON 11-14-2025
- Dividend Yield
- ELWS N/A
- AEON N/A
- EPS Growth
- ELWS N/A
- AEON N/A
- EPS
- ELWS N/A
- AEON N/A
- Revenue
- ELWS $3,083,071.00
- AEON N/A
- Revenue This Year
- ELWS N/A
- AEON N/A
- Revenue Next Year
- ELWS N/A
- AEON N/A
- P/E Ratio
- ELWS N/A
- AEON N/A
- Revenue Growth
- ELWS 145.52
- AEON N/A
- 52 Week Low
- ELWS $1.64
- AEON $0.38
- 52 Week High
- ELWS $10.50
- AEON $64.80
- Technical
- Relative Strength Index (RSI)
- ELWS 64.04
- AEON 42.87
- Support Level
- ELWS $5.41
- AEON $0.77
- Resistance Level
- ELWS $6.06
- AEON $1.14
- Average True Range (ATR)
- ELWS 0.52
- AEON 0.11
- MACD
- ELWS 0.07
- AEON -0.01
- Stochastic Oscillator
- ELWS 92.62
- AEON 16.33
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.